Mustang Bio, Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mustang Bio, Inc - overview
Location
Waltham, MA, US
Primary Industry
Pharmaceuticals
About
Based in the US, Mustang Bio, Inc, operates as a developer of cell therapies. Based in Waltham, the US, Mustang Bio, Inc was founded to focus on the development of innovative cell therapies. The company specializes in creating advanced manufacturing solutions for CAR T therapy, addressing unmet medical needs in cancer treatment. Mustang Bio has evolved its product offerings to include a range of cell therapy solutions, collaborating with healthcare providers to enhance treatment frameworks.
Mustang Bio specializes in the development of next-generation therapies, particularly focusing on cell therapeutics that offer enhanced uniformity and scalability. Their approach aims to create advanced manufacturing solutions that deliver the benefits of CAR T therapy to patients suffering from various forms of cancer. The company’s portfolio highlights their commitment to addressing unmet medical needs, targeting areas where conventional treatments may fall short. By collaborating with healthcare providers and institutions, Mustang Bio serves a diverse client base, including hospitals and research facilities across North America and parts of Europe.
Mustang Bio's revenue structure is intricately tied to their partnerships and collaborations within the biopharmaceutical sector. The company engages in B2B transactions, collaborating with research organizations and healthcare systems to further develop and commercialize their therapeutics. Revenue is generated through agreements that may include licensing arrangements and milestone payments tied to the successful advancement of their therapies. Mustang Bio's flagship products focus on cell therapy solutions designed to be integrated into existing treatment frameworks, targeting hospitals and specialty clinics as primary end customers.
The company plans to expand its product offerings in cell therapies and enhance its manufacturing capabilities. Current initiatives include developing partnerships with healthcare institutions to improve access to innovative therapeutic solutions.
Primary Industry
Pharmaceuticals
Website
www.mustangbio.com/
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.